A clinical trial from Wake Forest University School of Medicine shows that two widely available medications, the diabetes ...

Although teplizumab doesn’t work for everyone and how much it delays progression varies, it has inspired new directions in ...

Sodium-glucose cotransporter-2 (SGLT-2) inhibitors used to treat type 2 diabetes are associated with an 11% lower risk of ...

New research suggests that diabetes and weight-loss drugs known as GLP-1 receptor agonists may also help treat alcohol and ...

Henagliflozin, a diabetes treatment approved in China, may do more than just control blood sugar—it may actually slow ...

Researchers say GLP-1 drugs prescribed for weight loss like Ozempic and Mounjaro are more effective at reducing heart health ...

Orforglipron, a novel oral GLP-1, was superior to dapagliflozin for reducing HbA1c in adults with type 2 diabetes ...

In a study from Korea, adults with type 2 diabetes had a lower risk for autoimmune rheumatic diseases after starting an SGLT2 ...

The girl was diagnosed with stage 2 of the disease, a status that meant her own immune system was making at least two types ...

Non-adherence to at least one prescribed antidiabetic drug is highly common among patients with type 2 diabetes and rises ...

A well-established diabetes drug alleviated brain inflammation in a female mouse model of multiple sclerosis, suggesting the ...